Harnessing a Virus to Fight Brain Cancer: $2.5 Million NIH Award Advances Experimental Glioblastoma Therapy

Zika virus-based therapyPositive

AI Analysis

Summary

Rosalind Franklin University's Helix 51 incubator received a $2.5 million NIH award to advance an experimental Zika virus-based therapy for glioblastoma toward potential human clinical trials.

Outcome Details

$2.5 million NIH award advancing preclinical Zika virus-based glioblastoma therapy toward potential human clinical trials

Importance:3/10

Sentiment:

0.40

glioblastomabrain canceroncolytic virusZika virusNIH grantpreclinicalacademic research

Related Companies

$NHPAP

Read the original article

Published by PR Newswire Biotech on October 19, 2026 8:20 PM

Read Original